newsfilter
← Latest News
PR Newswire·

INVO Reports Fourth Quarter and Full Year 2022 Financial Results

Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., April 17, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ:INVO) ("INVO" or the "Company"), a commercial-stage fertility company